Healix Capital Partners delivers independent capital markets advice to private equity, founder-led businesses, corporates, and their boards. We help clients shape strategy, refine investor positioning, exit preperations, optimise valuation frameworks and capital allocation across healthcare, including medical devices, diagnostics, tools, and healthcare services. We bring the same expertise to Motorsport, advising on assets from karting platforms through to engineering, race teams, and premier race venues.
Healix Capital Partners brings deep expertise in the MedTech and Motorsport sector. The founder has worked across London, New York and Sydney with leading global investment banks including Merrill Lynch, Morgan Stanley and Jefferies, with experience spanning top-ranked equity research (ranked No. 1 by institutional investors for over a decade*) and mergers & acquisitions. Prior experience in audit at KPMG further enhances a comprehensive understanding of both private and public investing ecosystems.
*According to Institutional Investor and Extel Surveys
Helping companies and investors decide, when and how to pursue a transaction
Helping companies and investors define equity story and valuation framework
Ongoing support to PE funds – without stepping into execution
Coverage across most MedTech verticals, spanning from innovation, manufacturing, services and clinical applications
Laser, RF, ultrasound, injectables, regenerative
Plasma derivatives and transfusion technologies
Interventional, structural heart, EP, CRM
Restorative, orthodontics, intraoral scanners
Dialyzers, pumps, clinic infrastructure
Injection systems, pumps, syringes
We help simplify Motorsport
Decades of experience and networking across markets enables us to provide solutions to problems
Experience across North America, Europe, Asia Pacific, and beyond
Understanding of local markets and regulatory considerations
Private equity, long only and hedge funds
Experience during Asia crisis, Dot-com bubble, Global financial crisis, European sovereign debt crisis and Covid pandemic
